Spire Wealth Management - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 73 filers reported holding ACELRX PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.

Quarter-by-quarter ownership
Spire Wealth Management ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$2,000
-33.3%
3,540
+39.4%
0.00%
Q3 2021$3,000
-25.0%
2,5400.0%0.00%
Q1 2021$4,0002,5400.00%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
LINCOLN CAPITAL CORP 62,000$216,0000.20%
Monashee Investment Management LLC 187,190$651,0000.15%
Cedar Wealth Management, LLC 46,395$161,0000.10%
BCWM, LLC 35,100$122,0000.06%
Tibra Equities Europe Ltd 149,595$521,0000.05%
Ahrens Investment Partners LLC 30,900$108,0000.05%
ExodusPoint Capital Management, LP 151,904$529,0000.04%
Laurion Capital Management LP 833,400$2,900,0000.04%
Alpine Global Management, LLC 33,928$118,0000.03%
Cornerstone Capital, Inc. 57,550$200,0000.03%
View complete list of ACELRX PHARMACEUTICALS INC shareholders